Skip to main navigation Skip to search Skip to main content

WHO informal consultation on the guidelines for evaluation of the quality, safety, and efficacy of DNA vaccines, Geneva, Switzerland, December 2019

  • WHO informal consultation on development of guidelines for assuring the quality, safety, and efficacy of DNA vaccine
  • , Rebecca Sheets
  • , Hye Na Kang
  • , Heidi Meyer
  • Independent expert
  • World Health Organization
  • Paul-Ehrlich-Institut
  • Pharmacy and Poisons Board
  • Alimentosy Tecnología Medica (ANMAT)
  • Ministry of Food and Drug Safety
  • Agência Nacional de Vigilância Sanitária
  • Inovio Pharmaceuticals
  • National Institutes of Health
  • Health Canada
  • Central Drugs Standard Control Organization
  • Merck
  • Saudi Food and Drug Authority
  • Coalition for Epidemic Preparedness Innovations (CEPI)
  • PATH
  • Karolinska Institutet
  • GeneOne Life Science Inc
  • Food and Drugs Authority
  • GeneOne Life Science
  • Wistar Institute
  • United States Food and Drug Administration
  • Université Laval
  • Medicines and Healthcare Products Regulatory Agency
  • London School of Hygiene and Tropical Medicine
  • International Vaccine Institute, Seoul
  • National Medical Products Administration

Research output: Contribution to journalArticlepeer-review

9 Citations (Scopus)
Original languageEnglish
Article number52
Journalnpj Vaccines
Volume5
Issue number1
DOIs
Publication statusPublished - 1 Dec 2020
Externally publishedYes

UN SDGs

This output contributes to the following UN Sustainable Development Goals (SDGs)

  1. SDG 3 - Good Health and Well-being
    SDG 3 Good Health and Well-being

Cite this